Email Dr Varma

Tacrolimus (Protopic) Ointment

Tacrolimus was specifically developed for the treatment of eczema. It was first approved in Japan in 1999 for eczema. More than 19000 patients (including 7600 children) took part on the Tacrolimus ointment development programme. More than 5.4 million prescriptions have been issued worldwide.

No evidence of increased risk of malignancy in adults or children compared with the general population.1

This is an ointment that is used for the treatment of moderate to severe eczema in patients who have not responded to conventional treatment. Recently its use as a twice weekly application has been suggested to keep eczema at bay.

Reference

  1. Rustin MHA. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. BJD 2007; 157: 861-873

 

 

 

 

 

 

 
  Appointments
A-Z patient info leaflets
Acne Nottingham
Acne, Isotretinoin, Roaccutane
Acne in the over 40s
BCC
BCC treatment
Biography / Publications
Bloke in "chippy" saved my sight
Bowen's disease / IEC
BSDS
Contact / Appointments
Cysts
Early detection of skin cancer
Efudix
Eyelid Skin Cancer / BCC
Facial basal cell carcinoma
Golfers and skin cancer
Guidelines
Hair Loss
Home / Introduction
IEC / Bowen's disease
In the news
Imiquimod / Aldara
Is this mole a skin cancer
Keratoacanthoma
Laser Treatment
Lentigo Maligna

Links

Louise Sumner skincare
Melanoma
Melanoma Diagnosed
Mohs surgery
Mohs surgery in pictures
Moles and mole checks
Nottingham Dermatologist
Nottingham Nurse Surgery Course
Notts CCC screening 2004-16
Oregon Health & Sciences Univ PDT = Photodynamic therapy
Prevention of Skin Cancer
Profile / Publications
Red Faces
Rosacea
SCC
SKCIN
Skin cancer
Skin cancer charity
Skin cancer checks
Tacrolimus
Talks
Treatments I do / don't do
War Veterans and skin cancer
Warts
 
 
  © Dr Sandeep Varma Ltd. 2017
Site by Wizbit